FDA Grants Approval for BAVENCIO® (avelumab), the First Immunotherapy Approved for Metastatic Merkel Cell Carcinoma March 23, 2017October 19, 2019 by / Share This.....LinkedinTwitterFacebookGoogleEmailDownload PDF Related News: Thermo Fisher Scientific Recognizes Significance of…Roche’s Tecentriq approved by European Commission as…Roche receives FDA approval for first companion…Roche receives FDA approval for first companion…US FDA Advisory Committee votes in favour of…US FDA Advisory Committee votes in favour of…Share this:Click to share on Twitter (Opens in new window)Click to share on Facebook (Opens in new window)